Immunome to present at H.C. Wainwright 28th conference on Sept. 14, 2026
Immunome management will present at H.C. Wainwright’s 28th Annual Global Investment Conference on September 14, 2026, according to a company announcement.
Immunome, Inc. (Nasdaq: IMNM), a clinical-stage targeted oncology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced that Immunome management will present at H.C.
Wainwright’s 28th Annual Global Investment Conference on September 14, 2026, at 1…